| P2093 | author name string | Li Liu | |
| | Dawei Xu | |
| | Kun Wang | |
| | Catharina Larsson | |
| | Cheng Liu | |
| | Feng Kong | |
| | Kexin Wang | |
| | Omid Fotouhi | |
| | Guangyong Zhang | |
| | Sanyuan Hu | |
| | Benkang Shi | |
| | Yidong Fan | |
| | Chuanyou Xia | |
| P2860 | cites work | Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications | Q26738705 |
| | Analysis of fecal DNA methylation to detect gastrointestinal neoplasia | Q30491000 |
| | TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas | Q33688439 |
| | Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer | Q34100603 |
| | DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA | Q34141525 |
| | Regulation of the human catalytic subunit of telomerase (hTERT). | Q34180715 |
| | Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms | Q34369723 |
| | TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma | Q34654382 |
| | TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR | Q35068013 |
| | TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer | Q35151119 |
| | The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression | Q35741571 |
| | Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma. | Q36452245 |
| | Telomerase at the intersection of cancer and aging | Q37497995 |
| | Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer | Q37552649 |
| | Telomerase as a "stemness" enzyme | Q38211826 |
| | The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas | Q39076273 |
| | Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells | Q39263985 |
| | Cancer statistics in China, 2015. | Q40064386 |
| | hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site | Q40185373 |
| | DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. | Q40907825 |
| | Novel methylation panel for the early detection of colorectal tumors in stool DNA. | Q42965516 |
| | DNA methylation-based fecal biomarkers for the noninvasive screening of GI cancers | Q44108212 |
| | Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres | Q44590135 |
| | Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids | Q46577098 |
| | Multitarget stool DNA testing for colorectal-cancer screening | Q48331668 |
| | Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. | Q50859079 |
| | Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. | Q53387220 |
| | Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients | Q53452931 |
| | The absence of TERT promoter mutations in primary gastric cancer. | Q54374140 |
| | hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup. | Q54560829 |
| | Analysis of DNA methylation status of the promoter of human telomerase reverse transcriptase in gastric carcinogenesis. | Q54677342 |
| | Evaluation of telomerase mRNA (hTERT) in colon cancer | Q59219407 |
| | Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer | Q59300443 |
| | Catalytic Subunit of Human Telomerase Reverse Transcriptase Is an Independent Predictor of Survival in Patients Undergoing Curative Resection of Hepatic Colorectal Metastases: A Multicenter Analysis | Q60629744 |
| | Methylation of the human telomerase gene CpG island | Q73453061 |
| | Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT | Q74067288 |
| | Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia | Q77348257 |
| | Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues | Q79962935 |
| | Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma | Q80730166 |
| | CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells | Q81469389 |
| | Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths | Q83986260 |
| | The diagnostic value of DNA hypermethylation in stool for colorectal cancer: a meta-analysis | Q86766263 |
| P433 | issue | 10 | |
| P921 | main subject | biomarker | Q864574 |
| | hypermethylation | Q106875739 |
| P304 | page(s) | 1178-1188 | |
| P577 | publication date | 2017-07-28 | |
| P1433 | published in | Oncologist | Q2122327 |
| P1476 | title | TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker. | |
| P478 | volume | 22 | |